Treatment of Androgenetic Alopecia in Men for 24 Weeks

Summary

A prospective, randomized, double-blind, single-center, placebo-Controlled, parallel-group study to evaluate the efficacy and safety of a new pharmaceutical form Minoxidil 5% in men after 24 weeks of treatment. ⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).

Timeline

Start

2023-03-02

Primary completion

2024-03-06

Completion

2024-03-06

Drugs

Indications